TAVR has been among the default therapies for aortic stenosis patients for years now, but new 10-year data from the PARTNER 2A trial and the P2S3i Sapien 3 registry suggests that how long a valve will last depends heavily on the valve’s generation. To evaluate durability at the 10-year mark, both the PARTNER 2A and […] The post Ten Year TAVR Data and Why Valve Generations Matter appeared first on Cardiac Wire .